Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Alcofiltrum is an orally administered dietary supplement formulated to alleviate the severity of alcohol hangover symptoms through the combined action of its key ingredients: lignin hydrolyzed, dihydromyricetin, glycine, and thiamine (vitamin B1)[1][3][5][7]. - **Lignin hydrolyzed** is a plant-derived insoluble dietary fiber with a high sorption capacity for various toxic substances, most notably acetaldehyde and fusel alcohols, which contribute to hangover symptoms[1][3][5]. It also exhibits antioxidant and water-holding properties. - **Dihydromyricetin** is a natural flavonoid extracted from hovenia dulcis that counteracts the effects of ethanol intoxication by antagonizing ethanol's action on neuron cells and provides antioxidant benefits[1][3][5]. - **Glycine** is an amino acid neurotransmitter supporting healthy nervous system function and may help in neutralizing toxic alcohol metabolites[1][3][5]. - **Thiamine (Vitamin B1)** supports normal energy metabolism, which can be affected during alcohol hangovers, and contributes to proper nervous system function[1][3][5]. Alcofiltrum is clinically tested and shown to reduce the severity of several hangover symptoms including headache, weakness, sleep disturbance, and impaired concentration[3][9]. It comes in tablet form, each containing 800 mg lignin hydrolyzed, 150 mg glycine, 30 mg dihydromyricetin, and 30 mg vitamin B1[3][5]. The product is manufactured under GMP pharmaceutical standards for quality control[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Alcofiltrum.